Search

Search Results
Results 5581 - 5590 of 8666 for Skin Cancer
  • Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Testavan intended for persons living in Australia.
  • News - 21 Apr 2026
    Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from...
  • News - 21 Apr 2026
    Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery, according to research from a phase I clinical trial...
  • Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Darzalex SC intended for persons living in Australia.
  • Drug - 15 Apr 2026
    Consumer Medicine Information (CMI) about Ibrance tablets intended for persons living in Australia.
  • Drug - 13 Apr 2026
    Consumer Medicine Information (CMI) about Imbruvica intended for persons living in Australia.
  • News - 2 Apr 2026
    Ollie Super has moved in and out of cancer treatment since she was diagnosed with neuroblastoma as a toddler in foster care. Now 8, the second grader is dealing with it again. Her cancer came back...
  • News - 1 Apr 2026
    The National Comprehensive Cancer Network® (NCCN®)-a non-profit alliance of leading cancer centers-brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in...
  • News - 31 Mar 2026
    The review indicates nicotine e-cigarettes could surpass traditional quit aids in effectiveness, but lingering safety uncertainties warrant further research.
  • Drug - 30 Mar 2026
    Consumer Medicine Information (CMI) about Certican intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.